T Walters
Hospital for Sick Children
18 Papers
129 Citations
T Walters is an academic researcher from Hospital for Sick Children. The author has contributed to research in topics: Medicine & Crohn's disease. The author has an hindex of 8, co-authored 18 publications. Previous affiliations of T Walters include Royal Free London NHS Foundation Trust & University of Chicago.
Chat about Author
Papers
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
Robert Heuschkel,Camilla Salvestrini,R. Mark Beattie,Hans Hildebrand,T Walters,Anne M. Griffiths +5 more
TL;DR: A systematic review of publications was carried out to identify the best available evidence for managing growth failure in children with IBD, finding sufficient data to allow practical, evidence-based where possible, management guidelines to be formulated.
246
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension.
Jeffrey S. Hyams,T Walters,Wallace Crandall,Subra Kugathasan,Anne M. Griffiths,Marion Blank,Jewel Johanns,Yinghua Lang,James Markowitz,Stanley N. Cohen,Harland S. Winter,Gigi Veereman-Wauters,G. D. Ferry,Robert N. Baldassano +13 more
TL;DR: In REACH, the authors evaluated the long-term effects of maintenance infliximab therapy in children with moderately-to-severely active Crohn's disease, and the open-label extension (OLE) was used to provide up to three additional years of treatment.
103
Original article Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension
Jeffrey S. Hyams,T Walters,W Crandall,S. Kugathasan +3 more
- 01 Jan 2011
TL;DR: Among children with moderately-to-severely active Crohn’s disease who received infliximab for 46 weeks in REACH and then for up to 3 additional years in the REACH OLE, inflIXimab was effective in maintaining clinical benefit and was generally well-tolerated.
68
Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn’s disease and associated with decreased height
Amanda Ricciuto,Jennifer Fish,Diane Tomalty,Nicholas Carman,Eileen Crowley,Cynthia Popalis,A. Muise,T Walters,Anne M. Griffiths,Peter C Church +9 more
TL;DR: Investigating time to diagnosis in a paediatric inflammatory bowel disease (IBD) cohort and the relative contribution of the component intervals found diagnostic delay was more common in CD and associated with height impairment that persisted 1 year after presentation.
58
Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn’s Disease
Martinus A. Cozijnsen,Assaf Ben Shoham,Ben Kang,Byung-Ho Choe,Yon Ho Choe,Maria M E Jongsma,Richard K. Russell,Frank M. Ruemmele,Johanna C. Escher,Lissy de Ridder,Sibylle Koletzko,Javier Martín-de-Carpi,Jeffrey S. Hyams,T Walters,Anne M. Griffiths,Dan Turner +15 more
TL;DR: An index to non-invasively assess mucosal inflammation in children with CD, called the MINI index, identifies children with MH with high sensitivity and specificity, which is validated using data from 3 independent patient cohorts.
54